Tenet Healthcare Corp. Files 2023 Annual Report on Form 10-K
Ticker: THC · Form: 10-K · Filed: Feb 16, 2024 · CIK: 70318
Sentiment: neutral
Topics: Tenet Healthcare, 10-K, Annual Report, Healthcare, Financials
TL;DR
<b>Tenet Healthcare Corp. has filed its 2023 10-K annual report detailing its financial performance and operations for the year ending December 31, 2023.</b>
AI Summary
TENET HEALTHCARE CORP (THC) filed a Annual Report (10-K) with the SEC on February 16, 2024. Tenet Healthcare Corp. filed its annual report for the fiscal year ending December 31, 2023. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal business address is 14201 Dallas Parkway, Dallas, TX 75254. Tenet Healthcare Corp. was formerly known as National Medical Enterprises Inc. /NV/. The filing is a 10-K report filed under the Securities Exchange Act of 1934.
Why It Matters
For investors and stakeholders tracking TENET HEALTHCARE CORP, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Tenet Healthcare's financial health, operational performance, and strategic direction for the fiscal year 2023, crucial for investors and stakeholders to assess the company's current standing and future prospects. The detailed financial data and risk factors disclosed in this report are essential for understanding the company's market position, potential challenges, and compliance with regulatory requirements within the healthcare industry.
Risk Assessment
Risk Level: medium — TENET HEALTHCARE CORP shows moderate risk based on this filing. The company operates in the highly regulated healthcare industry, facing potential risks related to government regulations, reimbursement policies, and healthcare reform, which could materially impact its financial performance.
Analyst Insight
Investors should review the detailed financial statements and risk factors in the 10-K to assess Tenet Healthcare's performance and identify potential investment opportunities or risks.
Key Numbers
- 2023-12-31 — Fiscal Year End (Conformed Period of Report)
- 2024-02-16 — Filing Date (Filed as of Date)
- 159 — Public Document Count (Total documents in the filing)
- 8062 — Standard Industrial Classification (SIC code for Hospitals, NEC)
Key Players & Entities
- TENET HEALTHCARE CORP (company) — Filer name
- 0000070318 (company) — Central Index Key
- NATIONAL MEDICAL ENTERPRISES INC /NV/ (company) — Former company name
- 14201 DALLAS PARKWAY (company) — Business street address
- DALLAS (company) — Business city
- TX (company) — Business state
- 75254 (company) — Business zip code
- 469-893-2200 (company) — Business phone
FAQ
When did TENET HEALTHCARE CORP file this 10-K?
TENET HEALTHCARE CORP filed this Annual Report (10-K) with the SEC on February 16, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by TENET HEALTHCARE CORP (THC).
Where can I read the original 10-K filing from TENET HEALTHCARE CORP?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by TENET HEALTHCARE CORP.
What are the key takeaways from TENET HEALTHCARE CORP's 10-K?
TENET HEALTHCARE CORP filed this 10-K on February 16, 2024. Key takeaways: Tenet Healthcare Corp. filed its annual report for the fiscal year ending December 31, 2023.. The filing covers the period from January 1, 2023, to December 31, 2023.. The company's principal business address is 14201 Dallas Parkway, Dallas, TX 75254..
Is TENET HEALTHCARE CORP a risky investment based on this filing?
Based on this 10-K, TENET HEALTHCARE CORP presents a moderate-risk profile. The company operates in the highly regulated healthcare industry, facing potential risks related to government regulations, reimbursement policies, and healthcare reform, which could materially impact its financial performance.
What should investors do after reading TENET HEALTHCARE CORP's 10-K?
Investors should review the detailed financial statements and risk factors in the 10-K to assess Tenet Healthcare's performance and identify potential investment opportunities or risks. The overall sentiment from this filing is neutral.
How does TENET HEALTHCARE CORP compare to its industry peers?
Tenet Healthcare operates within the hospital and healthcare services industry, a sector characterized by significant regulatory oversight and evolving patient care models.
Are there regulatory concerns for TENET HEALTHCARE CORP?
The healthcare industry is subject to extensive federal and state regulations, including those related to patient care, billing, and data privacy (e.g., HIPAA), which Tenet Healthcare must adhere to.
Industry Context
Tenet Healthcare operates within the hospital and healthcare services industry, a sector characterized by significant regulatory oversight and evolving patient care models.
Regulatory Implications
The healthcare industry is subject to extensive federal and state regulations, including those related to patient care, billing, and data privacy (e.g., HIPAA), which Tenet Healthcare must adhere to.
What Investors Should Do
- Review the full 10-K filing for detailed financial statements and management's discussion and analysis.
- Analyze the risk factors section to understand potential challenges and uncertainties facing Tenet Healthcare.
- Compare the 2023 financial results with previous years to identify trends and performance changes.
Key Dates
- 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K filing.
- 2024-02-16: Filing Date — Date the 10-K report was officially submitted to the SEC.
Year-Over-Year Comparison
This filing represents the annual report for the fiscal year ending December 31, 2023, providing updated financial and operational information compared to previous filings.
Filing Stats: 4,427 words · 18 min read · ~15 pages · Grade level 17.3 · Accepted 2024-02-16 16:07:13
Key Financial Figures
- $0.05 — ange on which registered Common stock, $0.05 par value THC New York Stock Exchange
Filing Documents
- thc-20231231.htm (10-K) — 3915KB
- thc-20231231x10kex4a.htm (EX-4.A) — 74KB
- thc-20231231x10kex10ee.htm (EX-10.EE) — 35KB
- thc-20231231x10kex10ff.htm (EX-10.FF) — 19KB
- thc-20231231x10kex10l.htm (EX-10.L) — 386KB
- thc-20231231x10kex21.htm (EX-21) — 652KB
- thc-20231231x10kex23.htm (EX-23) — 2KB
- thc-20231231x10kex31a.htm (EX-31.A) — 10KB
- thc-20231231x10kex31b.htm (EX-31.B) — 9KB
- thc-20231231x10kex32.htm (EX-32) — 5KB
- thc-20231231x10kex97.htm (EX-97) — 9KB
- image_1.jpg (GRAPHIC) — 6KB
- image_1a.jpg (GRAPHIC) — 6KB
- thc-20231231_g1.jpg (GRAPHIC) — 388KB
- thc-20231231_g2.jpg (GRAPHIC) — 101KB
- 0000070318-24-000016.txt ( ) — 21911KB
- thc-20231231.xsd (EX-101.SCH) — 129KB
- thc-20231231_cal.xml (EX-101.CAL) — 180KB
- thc-20231231_def.xml (EX-101.DEF) — 720KB
- thc-20231231_lab.xml (EX-101.LAB) — 1556KB
- thc-20231231_pre.xml (EX-101.PRE) — 1094KB
- thc-20231231_htm.xml (XML) — 3310KB
Business
Business 1 Item 1A.
Risk Factors
Risk Factors 16 Item 1B. Unresolved Staff Comments 29 Item 1C. Cybersecurity 29 Item 2.
Properties
Properties 30 Item 3.
Legal Proceedings
Legal Proceedings 30 Item 4. Mine Safety Disclosures 30 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 31 Item 6. Reserved 32 Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 33 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 79 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data 80 Consolidated Financial Statements 84
Notes to Consolidated Financial Statements
Notes to Consolidated Financial Statements 89 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 132 Item 9A.
Controls and Procedures
Controls and Procedures 132 Item 9B. Other Information 132 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 132 PART III Item 10. Directors, Executive Officers and Corporate Governance 133 Item 11.
Executive Compensation
Executive Compensation 133 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 133 Item 13. Certain Relationships and Related Transactions, and Director Independence 133 Item 14. Principal Accounting Fees and Services 133 PART IV Item 15. Exhibits, Financial Statement Schedules 134 Item 16. Form 10-K Summary 140
Signatures
Signatures 141 i Table of Contents PART I.
BUSINESS
ITEM 1. BUSINESS OVERVIEW Tenet Healthcare Corporation ("Tenet") is a diversified healthcare services company with its headquarters in Dallas, Texas, and a Global Business Center ("GBC") supporting various administrative functions in Manila, Philippines. We operate our expansive, nationwide care delivery network through direct and indirect subsidiaries, as well as downstream partnerships and joint ventures; the terms "we," "our" and "us," as used in this report and unless otherwise stated or indicated by the context, refer to Tenet and these entities. Prior to December 31, 2023, our business was organized into three separate reporting segments: Hospital Operations and other, Ambulatory Care and Conifer. For the reasons discussed in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, of Part II of this report ("MD&A"), we combined our Hospital Operations and other and Conifer segments in the three months ended December 31, 2023. Our business is now classified into two separate reporting segments: Hospital Operations and Services ("Hospital Operations"), including: (i) 61 acute care and specialty hospitals, a network of employed physicians, and 164 outpatient facilities, including imaging centers, urgent care centers (each, a "UCC"), ancillary emergency facilities and microhospitals, at December 31, 2023; and (ii) the revenue cycle management and valuebased care services that our Conifer Health Solutions, LLC joint venture ("Conifer JV") provides to hospitals, health systems, physician practices, employers and other clients; and Ambulatory Care, which is comprised of the operations of our subsidiary USPI Holding Company, Inc. ("USPI"), which held indirect ownership interests in over 460 ambulatory surgery centers (each, an "ASC") and 24 surgical hospitals at December 31, 2023. All prior-period data presented in this report has been adjusted to conform to the new reporting segment structure described above. Additional in